XML 55 R75.htm IDEA: XBRL DOCUMENT v3.20.1
Share-based Compensation - Plan Information (Details) - shares
1 Months Ended 12 Months Ended 54 Months Ended
Jan. 01, 2020
Jan. 01, 2019
Jul. 30, 2018
Jun. 27, 2018
Jan. 01, 2018
Jun. 30, 2018
Dec. 31, 2019
Dec. 31, 2019
Jan. 01, 2016
Jul. 31, 2015
Nov. 30, 2009
Stock options outstanding | Performance based                      
Stock options, restricted stock and performance stock options                      
Vesting period             3 years        
Stock options | Minimum                      
Stock options, restricted stock and performance stock options                      
Vesting period             2 years        
Stock options | Maximum                      
Stock options, restricted stock and performance stock options                      
Vesting period             4 years        
Neos Therapeutics, Inc. 2009 Equity Plan                      
Stock options, restricted stock and performance stock options                      
Shares reserved for issuance under the plan                     1,375,037
Shares related to forfeited prior plan options transferred into shares available under current plan             351,229        
Neos Therapeutics, Inc. 2009 Equity Plan | Stock options                      
Stock options, restricted stock and performance stock options                      
Expiration period             10 years        
Expiration period of unexercised vested award after termination of employment             90 days        
Neos Therapeutics, Inc. 2009 Equity Plan | Restricted stock | Minimum                      
Stock options, restricted stock and performance stock options                      
Vesting period             1 month        
Neos Therapeutics, Inc. 2009 Equity Plan | Restricted stock | Maximum                      
Stock options, restricted stock and performance stock options                      
Vesting period             48 months        
Neos Therapeutics, Inc. 2015 Stock Option and Incentive Plan                      
Stock options, restricted stock and performance stock options                      
Shares reserved for issuance under the plan                   767,330  
Increase to the number of shares reserved and available for issuance as a percentage of outstanding common stock (as a percent)                 5.00%    
Increase in number of shares reserved and available for issuance   2,483,815     1,449,847            
Stock option exercise price, minimum expressed as percentage of fair market value on grant date             100.00%        
Shares related to forfeited prior plan options transferred into shares available under current plan               433,864      
Shares reserved and available for issuance             3,257,599 3,257,599      
Neos Therapeutics, Inc. 2015 Stock Option and Incentive Plan | Subsequent event                      
Stock options, restricted stock and performance stock options                      
Increase in number of shares reserved and available for issuance 2,486,633                    
Shares reserved and available for issuance 5,744,232                    
Neos Therapeutics, Inc. 2015 Stock Option and Incentive Plan | Stock options                      
Stock options, restricted stock and performance stock options                      
Expiration period             10 years        
Expiration period of unexercised vested award after termination of employment             90 days        
Neos Therapeutics, Inc 2018 Inducement Plan                      
Stock options, restricted stock and performance stock options                      
Shares reserved for issuance under the plan           800,000          
Stock option exercise price, minimum expressed as percentage of fair market value on grant date           100.00%          
Shares reserved and available for issuance             0 0      
Neos Therapeutics, Inc 2018 Inducement Plan | Stock options                      
Stock options, restricted stock and performance stock options                      
Expiration period           10 years          
Neos Therapeutics, Inc 2018 Inducement Plan | Stock options | Chief Executive Officer                      
Stock options, restricted stock and performance stock options                      
Vesting period       4 years              
Vested shares of the common stock subject to the option vests in equal installments over four years (in shares)     200,000 600,000